Prognostic value of combined preoperative phase angle and handgrip strength in cardiac surgery

Predicting post-procedural morbidity and mortality remains challenging despite the development of many scoring systems and prognostic algorithms in cardiac surgery [1, 2]. Hence, the assessment of novel biomarkers capable of guiding the modern physician in choosing the optimal, individualized, treatment for patients based on clinical prediction is of outmost importance [3].

The latest international guidelines support a more individualized patient management based on group discussion among cardiac specialists (i.e. “heart team”) and on the utilization of novel biomarkers such as frailty tests [4].Indicators of cellular integrity, functional capacity, and biological vulnerability have been recently proposed as preoperative risk factors associated with short- and long-term patient outcomes [5].In this context, phase angle (PA) [6] assessed with bioelectric impedance and handgrip strength (HS) [7] measured using a hand dynamometer emerge as valuable tools of promising cost-effectiveness with high reliability and accuracy, without posing a significant burden to the examiner. More specifically, PA, reflecting the resistance and reactance of cell membranes, and HS, reflecting the physical performance, have been already associated with sarcopenia, systemic inflammation, and increased morbidity and mortality burden [8].

In this prospective study enrolling patients undergoing selective open-heart surgery, we examined whether the combination of PA and HS values was associated with higher rates of one-year mortality, early morbidity and higher intensive care unit (ICU) stay. Our aim was to investigate the role of PA and HS in predicting clinical outcomes and enhancing pre-operative risk stratification in cardiac surgery patients.

Our study included 195 patients with a mean age of 67 years (SD: 9 years) of whom 150 were men (76.9%) and 45 women (23.1%). Of included patients, 90 suffered from coronary artery disease (46.2%), 87 (44.6%) from valvular disease and 18 from both (9.2%). Median EuroSCORE II was equal to 2.6%(0.6–15.5). Demographic and clinical characteristics of the overall study population and of the patients who survived compared to those who died during follow-up, are presented in Tables 1 and 2, respectively. PA was positively correlated with HS (r = 0.446 p < 0.005) and negatively with EUROSCORE II (r = − 0.306 p < 0.005) (Table 3). All patients were followed up for a median period of 1 year and no patients were lost during follow-up (drop-out rate = 0%). The median hospital and ICU stay were 9 days (IQR: 3 days) and 2 days (IQR: 2 days), respectively.

Regarding the primary study outcome, 27 patients (13.8%) died from any cause after one-year follow-up. PA, HS and their combination had a significant yet fair predictive value for all-cause mortality; PA: AUC (95% CI) 0.657 (0.54–0.77); p = 0.009, HS: AUC (95% CI) 0.659 (0.5–0.78); p = 0.008, and their combination: AUC (95% CI) 0.671 (0.56–0.78); p = 0.004 (Table 4).

The PA–HS combination had a significant effect on mortality occurrence [p = 0.009]. Patients with PA < 5.15 and HS < 25.5 were 5 times more likely to die [5.13 (1.84–14.27); p = 0.002] when compared to those with PA > 5.15–HS > 25.5 (Table 5). The multivariate analysis, presented in Table 6, yielded that female gender [0.27 (0.08–0.94); p = 0.040], Euroscore II [1.59 (1.17–2.14); p = 0.003] and the combination of PA–HS [p = 0.005] had an independent effect on mortality. Regarding the PA–HS combination, patients with PA < 5.15 and HS < 25.5 were 9.3 times more likely to die [9.28 (2.50–34.45); p = 0.001] in relation to those with PA > 5.15–HS > 25.5 (Table 6).

Α multivariate regression model for the prediction of 1-year mortality using PA and HS as continuous variables was also performed and is presented in Additional file 1: Table S1. According to this analysis, increased HS was independently linked with decreased all-cause mortality rates (aOR = 0.90, 95% CI: 0.84–0.96).

With regard to the secondary study outcome, the PA–HS combination was significantly associated with prolonged stay in the ICU [p = 0.002]. Patients with PA < 5.15 and HS < 30.7 were 4 times more likely to stay in the ICU for more than 1 day [4.14 (1.95–8.80); p = 0.001] in comparison with those having PA > 5.15 and HS > 30.7 (Table 7). PA, HS and their combination had also a significant yet poor predictive value for the prolonged stay in the ICU; PA: AUC (95% CI) = 0.600 (0.52–0.68); p = 0.016, HS: AUC (95% CI) = 0.586 (0.51–0.67); p = 0.040, and their combination: AUC (95% CI) = 0.597 (0.52–0.68); p = 0.019 (Table 4).

Multivariate analysis for the prediction of prolonged ICU stay demonstrated that female gender [0.35 (0.15–0.83); p = 0.017], EuroSCORE II [1.71 (1.27–2.30); p < 0.005], left ventricular ejection fraction [1.05 (1.01–1.10); p = 0.018] and the combination of PA–HS [p = 0.038] were independent predictors. Regarding the combination of those indicators, patients with PA < 5.15 and HS < 30.7 were found to be 4 times more likely to stay in the ICU for more than 1 day [4.02 (1.53–10.56); p = 0.005] compared to those with PA > 5.15–HS > 30.7 (Table 8).

Α multivariate regression model for the prediction of ICU stay using PA and HS as continuous variables was also performed and is presented in Additional file 1: Table S2. According to that analysis, increased HS was independently associated with decreased ICU LOS (aOR = 0.95, 95% CI: 0.90–0.99).

In order to observe the relationship between the PA–HS combination and the standard EuroSCORE II risk index, an analysis of variance (ANOVA) was performed, showing a statistically significant difference in EuroSCORE II values among individuals with PA < 5.15–HS < 25.5 compared to those with PA > 5.15–HS > 25.5 in mortality (Table 9).

Statistical tests of collinearity were also performed for each one of the multivariate analyses to investigate if there is any source of collinearity which could decrease the value of the independent effect (Additional file 1: Table S3). No significant source of collinearity was identified since every calculated Tolerance was greater than 0.2 and the calculated variance inflation factors (VIFs) were relatively low.

The results of this prospective observational study suggest the potential prognostic value of the combined preoperative PA–HS measurement as a new biomarker for predicting one-year mortality in cardiac patients undergoing selective cardiac surgery. According to our analyses, patients having a combination of low PA and HS values were 5 times more likely to die and 4 times more likely to remain in the ICU for more than one postoperative day, thus increasing postoperative morbidity and the likelihood of complications. Furthermore, the EuroSCORE II index, an internationally established risk index for death after cardiac surgery, was associated with the combination of PA–HS. To our knowledge, this is the first study examining whether the combination of PA and HS values is associated with one-year mortality rates and early morbidity in patients undergoing cardiac surgery, and could thereby enhance their pre-operative risk stratification.

From the literature review, low PA is associated with nutritional risk, increased morbidity and mortality in immunocompromised patients or patients with chronic kidney disease [8]. It has been particularly associated with poor functional status and worse prognosis in cancer patients [8]. PA is often lower than normal in diseased individuals, since infection, systemic inflammation or specific parameters of a disease may cause cell destruction and consequent reduction in PA [8, 9]. PA is positively correlated with total body protein, muscle mass, offering a qualitative dynamic aspect of the body's functional state [10]. Moreover, low PA values have been associated with weakness, vulnerability (frailty) and mortality, regardless of age and other comorbidities [11, 12].

According to the BICS (Bioimpedance in Cardiac Surgery) study enrolling 277 patients undergoing major cardiac surgery in Canada, PA can independently predict early and midterm mortality after major cardiac surgery [6]. A PA cutoff of < 4.5° had the highest predictive value for 1-year mortality, and every 1° decrease in PA conferred an almost threefold higher risk of mortality. Our analysis yielded a cut-off point of PA = 5.15° for the prediction of increased mortality and ICU stay. Additionally, PA has been suggested as a dynamic marker with the potential to respond to targeted interventions aiming to restore adequate nutritional status, increase physical activity, and optimize fluid status [6].

The measurement of HS is the most commonly used indicator for muscle function in several clinical conditions, as it is considered a strong indicator of functional capacity of the muscles as well as an indicative point of a patient’s nutritional status. The correlation between nutritional status and HS is well documented [13, 14]. Previous studies have also shown that HS was correlated with the severity of the disease, with aging and mortality in elderly individuals [15, 16]. Particularly in cardiac surgery, HS has been well-recognized as a preoperative risk assessment tool since weak HS has been associated with 1-year and 30-day mortality, heart failure, kidney disease, malnutrition, and various frailty scales [17‐19]. Hence, our study concurs with the growing body of literature regarding the poor outcomes of cardiac surgery patients with low preoperative PA and HS, and adds that their combined assessment might be an option to consider as a risk stratification tool.

Nevertheless, our study is subject to several limitations. Τhe small sample size, the limited follow-up and the monocentric study design restrict the generalizability of our findings. Secondly, we could not precisely record the dates of patients’ deaths and, therefore, survival analyses could not be performed. Furthermore, major adverse cardiovascular events and re-admissions were not documented in our database. Additionally, PA was not standardized for its direct determinants: age, gender and BMI, which could affect our results; however, we have adjusted our multivariate analyses for age and gender, while BMI was not univariately associated with either mortality or ICU LOS. Nevertheless, PA standardization prior to statistical analyses might be considered in future studies [20, 21]. Moreover, the characterization of prolonged ICU-stay as staying in ICU for more than 1 day was based on relevant studies [22‐25], but not analyzing it as a continuous variable might cause potential misinterpretation of our results. However, PA and HS have not been sufficiently studied in the specific patient population; hence, our results seem to be promising for their utilization and could trigger future studies to combine these biomarkers and associate them with postoperative prognosis. Thereby, we could ultimately achieve a more detailed holistic risk stratification of patients undergoing cardiac surgery and possibly direct them towards other alternative treatments such as angioplasty, valvular replacement or optimal palliative care.

In this prospective observational study, the combination of low preoperative PA and HS values was significantly associated with higher risk of all-cause mortality at 12 months and prolonged ICU stay. Hence, these clinical biomarkers could serve as prognostic tools for assessing adverse clinical course after cardiac surgery procedures. Larger studies and randomized-controlled trials are needed to confirm these results.